Cingulate CINGW
NASDAQ CINGW
$0.01 +0.00 (+4.29%)
As of: Sep 9, 2026 · 11:16 AM EDT

Cingulate (CINGW) Net Shares Issued and Repurchased (2021 - 2026)

Cingulate's (CINGW) quarterly Net Shares Issued and Repurchased came in at $3860.0 in Q2 2026, down 93.67% on a YoY basis from $61005.0 in Q2 2025, and down 99.56% quarter-over-quarter from $868901.0 in Q4 2025.

Analysis

Cingulate (CINGW) Net Shares Issued and Repurchased (2021 - 2026) Analysis & Trends

Cingulate (CINGW) has reported Net Shares Issued and Repurchased for 6 consecutive years, with $3860.0 the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Net Shares Issued and Repurchased fell 93.67% year-over-year to $3860.0; the trailing twelve-month figure through Jun 2026 stood at $3860.0 (down 93.67% YoY), and the FY2025 full-year result was $868901.0, up 875.94% from the prior year.
  • Net Shares Issued and Repurchased retreated to $3860.0 in Q2 2026 per CINGW's latest filing, from $868901.0 in the prior quarter.
  • Across five years, Net Shares Issued and Repurchased topped out at $868901.0 in Q4 2025 and bottomed at $2000.0 in Q3 2024.
  • Historically, Net Shares Issued and Repurchased has averaged $151355.9 across 5 years, with a median of $61005.0 in 2025.
  • The sharpest annual moves came in 2024 and 2025: Net Shares Issued and Repurchased tumbled 98.08% in 2024, then jumped 27541.9% in 2025.
  • Over 5 years, Net Shares Issued and Repurchased stood at $18017.0 in 2022, then sank by 85.29% to $2651.0 in 2023, then soared by 3258.43% to $89032.0 in 2024, then jumped by 875.94% to $868901.0 in 2025, then plunged by 99.56% to $3860.0 in 2026.
  • According to Business Quant data, Net Shares Issued and Repurchased over the past three periods registered $3860.0, $868901.0, and $552838.0 for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued and Repurchased (Qtr)
1 Johnson & Johnson 646.10 Bn 625.34 Bn 17.26 Bn -
2 AbbVie 441.68 Bn 435.11 Bn 12.70 Bn -
3 Merck 366.62 Bn 359.48 Bn 12.21 Bn -
4 Novartis Ag 266.55 Bn 258.86 Bn 11.24 Bn -3.07 Bn
5 Pfizer 159.14 Bn 147.45 Bn 10.94 Bn -
6 Sanofi 52.40 Bn 45.02 Bn 10.79 Bn -
7 Revolution Medicines 44.07 Bn 44.07 Bn - -
8 Incyte 25.59 Bn 21.05 Bn 1.57 Bn -
9 United Therapeutics 21.54 Bn 18.88 Bn 683.80 Mn -
10 Cingulate 100,214.03 100,214.03 - 3,860.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3,860.00
Dec 31, 2025 868,901.00
Sep 30, 2025 552,838.00
Jun 30, 2025 61,005.00
Mar 31, 2025 248,428.00
Dec 31, 2024 89,032.00
Sep 30, 2024 2,000.00
Jun 30, 2024 69,038.00
Mar 31, 2024 15,994.00
Dec 31, 2023 2,651.00
Sep 30, 2023 104,066.00
Jun 30, 2023 127,758.00
Mar 31, 2023 19,225.00
Dec 31, 2022 18,017.00
Sep 30, 2022 29,721.00
Jun 30, 2022 17,517.00
Mar 31, 2022 342,999.00
Dec 31, 2021 523,285.00